切换至 "中华医学电子期刊资源库"

中华肝脏外科手术学电子杂志 ›› 2019, Vol. 08 ›› Issue (03) : 230 -233. doi: 10.3877/cma.j.issn.2095-3232.2019.03.012

所属专题: 文献

临床研究

超声引导下纳米刀治疗不可切除的局部进展期胰腺癌
苏丽娅1, 林满霞1, 陈泽斌2, 谢晓燕1, 匡铭3,()   
  1. 1. 510080 广州,中山大学附属第一医院介入超声科
    2. 510080 广州,中山大学附属第一医院肝脏外科
    3. 510080 广州,中山大学附属第一医院介入超声科;510080 广州,中山大学附属第一医院肝脏外科
  • 收稿日期:2019-02-18 出版日期:2019-06-10
  • 通信作者: 匡铭
  • 基金资助:
    广东省科技计划项目(2016A020215189); 广州市科技计划-民生科技项目(201704020099)

Ultrasound-guided irreversible electroporation in treatment of unresectable locally advanced pancreatic cancer

Liya Su1, Manxia Lin1, Zebin Chen2, Xiaoyan Xie1, Ming Kuang3,()   

  1. 1. Department of Interventional Ultrasound, the First Affiliated Hospital of Sun Yat-sen University, Guangzhou 510080, China
    2. Department of Liver Surgery, the First Affiliated Hospital of Sun Yat-sen University, Guangzhou 510080, China
    3. Department of Interventional Ultrasound, the First Affiliated Hospital of Sun Yat-sen University, Guangzhou 510080, China; Department of Liver Surgery, the First Affiliated Hospital of Sun Yat-sen University, Guangzhou 510080, China
  • Received:2019-02-18 Published:2019-06-10
  • Corresponding author: Ming Kuang
  • About author:
    Corresponding author: Kuang Ming, Email:
引用本文:

苏丽娅, 林满霞, 陈泽斌, 谢晓燕, 匡铭. 超声引导下纳米刀治疗不可切除的局部进展期胰腺癌[J/OL]. 中华肝脏外科手术学电子杂志, 2019, 08(03): 230-233.

Liya Su, Manxia Lin, Zebin Chen, Xiaoyan Xie, Ming Kuang. Ultrasound-guided irreversible electroporation in treatment of unresectable locally advanced pancreatic cancer[J/OL]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2019, 08(03): 230-233.

目的

评估超声引导下纳米刀消融技术在治疗不可切除的局部进展期胰腺癌(LAPC)中的安全性及有效性。

方法

回顾性分析2015年9月至2016年5月在中山大学附属第一医院就诊的15例不可切除的LAPC患者临床资料。其中男9例,女6例;年龄34~75岁,中位年龄61岁。肿瘤直径2.1~7.2 cm,中位直径4.4 cm。患者均签署知情同意书,符合医学伦理学规定。患者均接受超声引导下开腹纳米刀消融治疗。观察术中、术后的消融效果,围手术期并发症及生存情况。

结果

所有患者均顺利完成手术,术中超声评估消融效果满意。术后1 d胰腺超声造影检查显示所有患者的肿瘤均完全消融,未见周围血管、胰管、胆管、肠道等组织结构严重损伤。术后轻度发热2例,疼痛2例,胃肠道不适3例,感染1例,胆管炎1例,均对症治疗后痊愈。术后平均住院时间(12±4) d。患者中位生存期为10个月,生存时间>1年者5例,其中3例接受术后化疗。

结论

超声引导下纳米刀消融技术治疗不可切除的LAPC是一种安全、有效的治疗方法,相比传统手术具有治疗周期短、并发症少、恢复快等优点。纳米刀消融术后联合化疗可改善患者预后。

Objective

To evaluate the safety and efficacy of ultrasound-guided irreversible electroporation (IRE) in the treatment of unresectable locally advanced pancreatic cancer (LAPC).

Methods

Clinical data of 15 patients with unresectable LAPC admitted to the First Affiliated Hospital of Sun Yat-sen University from September 2015 to May 2016 were retrospectively analyzed. Among them, 9 patients were male and 6 female, aged 34-75 years with a median age of 61 years. The tumor diameter was ranged from 2.1 to 7.2 cm with a median of 4.4 cm. The informed consents of all patients were obtained and the local ethical committee approval was received. All patients received ultrasound-guided laparotomy IRE. The intra- and post-operative ablation effect, perioperative complications and survival of the patients were observed.

Results

All the patients underwent the operation successfully, and the ablation effect was satisfactory evaluated by intraoperative ultrasound. Contrast-enhanced ultrasound of the pancreas at postoperative 1 d demonstrated that tumors of all the patients were ablated completely, and no severe injuries were observed in the peripheral vessels, pancreatic duct, bile duct, intestinal tract and other tissues. 2 cases developed mild fever, 2 cases of pain, 3 cases of gastrointestinal discomfort, 1 case of infection and 1 case of cholangitis were observed after operation. All were cured with symptomatic treatments. The average postoperative length of hospital stay was (12±4) d. The median survival was 10 months. 5 patients survived for over 1 year, 3 of whom received chemotherapy after operation.

Conclusions

Ultrasound-guided IRE is a safe and efficacious treatment for unresectable LAPC. Compared with the traditional operations, it has the advantages of shorter treatment period, less postoperative complications and faster recovery, etc. IRE combined with postoperative chemotherapy can improve the clinical prognosis of patients.

表1 15例不可切除的局部进展期胰腺癌患者肿瘤情况
[1]
吉王明,周丁华.胰腺癌的局部消融治疗现状[J].中国医学工程,2011, 19(4):171-172.
[2]
Wilkowski R,Boeck S,Ostermaier S, et al. Chemoradiotherapy with concurrent gemcitabine and cisplatin with or without sequential chemotherapy with gemcitabine/cisplatin vs chemoradiotherapy with concurrent 5-fluorouracil in patients with locally advanced pancreatic cancer-a multicentre randomised phase Ⅱ study[J]. Br J Cancer, 2009, 101(11):1853-1859.
[3]
Zhang X,Tian J,Zhao L, et al. CT-guided conformal cryoablation for peripheral NSCLC: initial experience[J]. Eur J Radiol, 2012, 81(11):3354-3362.
[4]
周瑜,吴志远,丁晓毅.不可逆电穿孔消融治疗胰腺癌的现状与展望[J/CD].中华介入放射学电子杂志,2017, 5(3):194-198.
[5]
Zhang Y,Lyu C,Liu Y, et al. Molecular and histological study on the effects of non-thermal irreversible electroporation on the liver[J]. Biochem Biophys Res Commun, 2018, 500(3):665-670.
[6]
Charpentier KP,Wolf F,Nobel L, et al. Irreversible electroporation of the pancreas in swine: a pilot study[J]. HPB, 2010, 12(5):348-351.
[7]
Philips P,Li Y,Li S, et al. Efficacy of irreversible electroporation in human pancreatic adenocarcinoma: advanced murine model[J]. Mol Ther Methods Clin Dev, 2015(2):15001.
[8]
Lin M,Xie X,Xu M, et al. Non-enhanced pattern on contrast-enhanced ultrasound in the local efficacy assessment of irreversible electroporation ablation of pancreatic adenocarcinoma[J]. Ultrasound Med Biol, 2018, 44(9):1986-1995.
[9]
Paiella S,Salvia R,Girelli R, et al. Role of local ablative techniques (radiofrequency ablation and irreversible electroporation) in the treatment of pancreatic cancer[J]. Updates Surg, 2016, 68(3):307-311.
[10]
Rubinsky B,Onik G,Mikus P. Irreversible electroporation: a new ablation modality-clinical implications[J]. Technol Cancer Res Treat, 2007, 6(1):37-48.
[11]
Lee EW,Loh CT,Kee ST. Imaging-guided percutaneous irreversible electroporation: ultrasound and immunohistological correlation[J]. Technol Cancer Res Treat, 2007, 6(4):287-294.
[12]
赵刚.NCCN2017年第2版胰腺癌临床实践指南解读(纳米刀应用之我见)[J].临床外科杂志,2018, 26(1):25-28.
[13]
牛立志,曾健滢,张怡湜,等.不可逆电穿孔消融治疗胰腺癌的安全性及近期疗效观察[J].介入放射学杂志,2016, 25(3):225-230.
[14]
林满霞,谢晓燕,匡铭, 等. 超声引导下纳米刀治疗危险部位恶性肿瘤的短期疗效及安全性评价[J]. 中国超声医学杂志, 2017, 33(5): 443-446.
[15]
Martin RC 2nd,Kwon D,Chalikonda S, et al. Treatment of 200 locally advanced (stage Ⅲ) pancreatic adenocarcinoma patients with irreversible electroporation: safety and efficacy[J]. Ann Surg, 2015, 262(3):486-494.
[16]
Martin RC 2nd,McFarland K,Ellis S, et al. Irreversible electroporation in locally advanced pancreatic cancer: potential improved overall survival[J]. Ann Surg Oncol, 2013,20 Suppl 3: 443-449.
[17]
Martin RC. Irreversible electroporation of locally advanced pancreatic head adenocarcinoma[J]. J Gastrointest Surg, 2013, 17(10):1805-1806.
[18]
Conroy T,Gavoille C,Samalin E, et al. The role of the FOLFIRINOX regimen for advanced pancreatic cancer[J]. Curr Oncol Rep, 2013, 15(2):182-189.
[1] 章建全, 程杰, 陈红琼, 闫磊. 采用ACR-TIRADS评估甲状腺消融区的调查研究[J/OL]. 中华医学超声杂志(电子版), 2024, 21(10): 966-971.
[2] 罗辉, 方晔. 品管圈在提高甲状腺结节细针穿刺检出率中的应用[J/OL]. 中华医学超声杂志(电子版), 2024, 21(10): 972-977.
[3] 杨忠, 时敬业, 邓学东, 姜纬, 殷林亮, 潘琦, 梁泓, 马建芳, 王珍奇, 张俊, 董姗姗. 产前超声在胎儿22q11.2 微缺失综合征中的应用价值[J/OL]. 中华医学超声杂志(电子版), 2024, 21(09): 852-858.
[4] 孙佳丽, 金琳, 沈崔琴, 陈晴晴, 林艳萍, 李朝军, 徐栋. 机器人辅助超声引导下经皮穿刺的体外实验研究[J/OL]. 中华医学超声杂志(电子版), 2024, 21(09): 884-889.
[5] 史学兵, 谢迎东, 谢霓, 徐超丽, 杨斌, 孙帼. 声辐射力弹性成像对不可切除肝细胞癌门静脉癌栓患者放射治疗效果的评价[J/OL]. 中华医学超声杂志(电子版), 2024, 21(08): 778-784.
[6] 李洋, 蔡金玉, 党晓智, 常婉英, 巨艳, 高毅, 宋宏萍. 基于深度学习的乳腺超声应变弹性图像生成模型的应用研究[J/OL]. 中华医学超声杂志(电子版), 2024, 21(06): 563-570.
[7] 洪玮, 叶细容, 刘枝红, 杨银凤, 吕志红. 超声影像组学联合临床病理特征预测乳腺癌新辅助化疗完全病理缓解的价值[J/OL]. 中华医学超声杂志(电子版), 2024, 21(06): 571-579.
[8] 项文静, 徐燕, 茹彤, 郑明明, 顾燕, 戴晨燕, 朱湘玉, 严陈晨. 神经学超声检查在产前诊断胼胝体异常中的应用价值[J/OL]. 中华医学超声杂志(电子版), 2024, 21(05): 470-476.
[9] 胡可, 鲁蓉. 基于多参数超声特征的中老年女性压力性尿失禁诊断模型研究[J/OL]. 中华医学超声杂志(电子版), 2024, 21(05): 477-483.
[10] 张妍, 原韶玲, 史泽洪, 郭馨阳, 牛菁华. 小肾肿瘤超声漏诊原因分析新思路[J/OL]. 中华医学超声杂志(电子版), 2024, 21(05): 500-504.
[11] 席芬, 张培培, 孝梦甦, 刘真真, 张一休, 张璟, 朱庆莉, 孟华. 乳腺错构瘤的临床与超声影像学特征分析[J/OL]. 中华医学超声杂志(电子版), 2024, 21(05): 505-510.
[12] 钱警语, 郑明明. 《2024意大利妇产科学会非侵入性和侵入性产前诊断指南》解读[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(05): 486-492.
[13] 付成旺, 杨大刚, 王榕, 李福堂. 营养与炎症指标在可切除胰腺癌中的研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 704-708.
[14] 魏孔源, 仵正, 王铮, 黎韡. 机器人胰腺中段切除后远端胰腺消化道不同重建方式初探[J/OL]. 中华腔镜外科杂志(电子版), 2024, 17(05): 295-300.
[15] 张琛, 秦鸣, 董娟, 陈玉龙. 超声检查对儿童肠扭转缺血性改变的诊断价值[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 565-568.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?